Genzyme OKs $2B buyback, mulls options for 3 units | The Associated Press thefresnobee_994:/2010/05/06/1923854/genzyme-oks-2b-buyback-mulls-options.html E-Mail Print Text Size: tool name | tool goes here Comments (0) | Similar stories: | Bristol-Myers... (photo: Creative Commons / Antonio1990) Fresno Bee
Vertex drug not enough to fight off hepatitis C | SAN FRANCISCO - Inc.'s experimental hepatitis C treatment knocks out so much of the rapidly mutating virus it lets drug-resistant strains grow instead, requiring multidrug cocktails to defeat it, a ... (photo: Creative Commons / ShellyS)The Boston Globe DrugHealthHepatitisPhotosTreatment
Merck and Ariad restructure cancer drug deal | NEW YORK-Merck and Ariad Pharmaceuticals are restructuring how they develop a potential cancer drug, with Merck saying Wednesday it will cover all development costs in ... (photo: AP / Mel Evans, file)The Boston Globe AriadCancerDrugMerckPhotos
The medicinal power of spring rhubarb | Rhubarb photo D.Bock If you like this ... Treatment strategy Drugs and herbs The difference between herbal medicine and herbal marketing What are frankincense and myrrh... (photo: WN / Aruna Mirasdar)The Examiner DrugsPhotoPhotosPowerTreatment
Kristin Cavallari off all drugs | The Hills star Kristin Cavallari has fired back at reports she was caught snorting cocaine backstage at the Coachella festival in California last month, insisting she d... (photo: WN / Aruna Gilbert)Jam Entertainment ActressCelebrityEntertainmentPhotosStar
Pfizer and Merck Beat Earnings Forecasts | The drug companies Pfizer Inc and Merck & Company posted better-than-expected first-quarter results Tuesday and stood by their long-term forecasts. Add to Portfolio | P... (photo: AP / Mary Altaffer)The New York Times BusinessDrugsMarketPhotosUS
